Funding & Benefits
Research Opportunities to Impact COVID-19
COVID-19 Funding Opportunities
Internal and external funding opportunties related to COVID-19 research.
Early Stage Translational Projects
In response to the unprecedented COVID-19 pandemic, applications received related to resources for COVID-19 related projects shall be reviewed on a rolling basis by the Center Leadership Teams for quicker turnaround time.
Applied Seed Funds
Manning/IALS Innovation Awards
UMass Amherst has created a new ‘Proof-of-Concept’ (POC) Seed Fund Program that will provide Innovation Awards of up to $100,000/award to advance translational and applied R&D efforts from faculty groups and/or startup companies.
Significant funding for this program comes from a gift to CNS from the Manning Family Foundation, and from the IALS Seed fund program. Additional contributions come from the College of Natural Sciences, the Berthiaume Center, the Isenberg School of Management, and the Office of Development and Alumni Relations.
Joint Funding with UMass Amherst & UMass Medical School
Collaborative Cancer Research Grant
UMA/UMMS faculty are invited to apply for joint Translational Pilot Grants for Cancer Research. These awards are to advance collaborative translational and applied R&D efforts from faculty groups, leading to follow-on extramural translational research funding.
Pilot grants are up to $75,000 per year. Funds are to support collaborative cancer research projects involving UMMS and UMA faculty members. Projects may be eligible for second year funding pending submission of a progress report documenting significant progress during the first year.